rs3827478
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000200639.9(LAMP2):c.*2746A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00576 in 1,197,967 control chromosomes in the GnomAD database, including 126 homozygotes. There are 2,297 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 19 hom., 490 hem., cov: 23)
Exomes 𝑓: 0.0049 ( 107 hom. 1807 hem. )
Consequence
LAMP2
ENST00000200639.9 3_prime_UTR
ENST00000200639.9 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.524
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant X-120428577-T-C is Benign according to our data. Variant chrX-120428577-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 43956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-120428577-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0653 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.*2746A>G | 3_prime_UTR_variant | 9/9 | ENST00000200639.9 | NP_002285.1 | ||
LAMP2 | NM_001122606.1 | c.1143A>G | p.Ala381= | synonymous_variant | 9/9 | NP_001116078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000434600.6 | c.1143A>G | p.Ala381= | synonymous_variant | 9/9 | 1 | ENSP00000408411 | A1 | ||
LAMP2 | ENST00000200639.9 | c.*2746A>G | 3_prime_UTR_variant | 9/9 | 1 | NM_002294.3 | ENSP00000200639 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0143 AC: 1595AN: 111836Hom.: 19 Cov.: 23 AF XY: 0.0144 AC XY: 490AN XY: 34070
GnomAD3 genomes
AF:
AC:
1595
AN:
111836
Hom.:
Cov.:
23
AF XY:
AC XY:
490
AN XY:
34070
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0102 AC: 1644AN: 161044Hom.: 36 AF XY: 0.00812 AC XY: 413AN XY: 50868
GnomAD3 exomes
AF:
AC:
1644
AN:
161044
Hom.:
AF XY:
AC XY:
413
AN XY:
50868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00488 AC: 5301AN: 1086077Hom.: 107 Cov.: 28 AF XY: 0.00511 AC XY: 1807AN XY: 353869
GnomAD4 exome
AF:
AC:
5301
AN:
1086077
Hom.:
Cov.:
28
AF XY:
AC XY:
1807
AN XY:
353869
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0143 AC: 1598AN: 111890Hom.: 19 Cov.: 23 AF XY: 0.0144 AC XY: 490AN XY: 34134
GnomAD4 genome
AF:
AC:
1598
AN:
111890
Hom.:
Cov.:
23
AF XY:
AC XY:
490
AN XY:
34134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 30, 2011 | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Danon disease Benign:2
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 22, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Hypertrophic cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at